News
- Author:
- Will Pass
Publish date: March 27, 2020
Differences in metabolism of levodopa between patients with Parkinson’s disease may be caused by variations in abundance of the gut bacteria En...
News
- Author:
- Will Pass
Publish date: March 26, 2020
Most patients were cured of C. difficile after one fecal transplant.
News
- Author:
- Will Pass
Publish date: March 19, 2020
Mechanisms of damage remain unclear, but could include virus-, immune-, or drug-induced injury.
News
- Author:
- Will Pass
Publish date: March 17, 2020
Coexisting heart disease, kidney disease, advanced age, and frailty are likely to further increase the severity of disease.
News
- Author:
- Will Pass
Publish date: March 16, 2020
Most articles detailing phase 3 cancer trials did not include safety or efficacy results that were stratified by age.
News
- Author:
- Will Pass
Publish date: March 13, 2020
Proton pump inhibitors (PPIs) alter the microbiome, which may interfere with other drugs and increase risks of other conditions, yet many patients ...
News
- Author:
- Will Pass
Publish date: March 13, 2020
“What happens in [the] vagus doesn’t just stay in vagus, but will actually affect our emotions in different ways,” Dr. Cryan said.
News
- Author:
- Will Pass
Publish date: March 11, 2020
To be of use for the clinician and general practitioner, microbiome profiling will have to rely on pipelines of standardized preanalytical and anal...
News
- Author:
- Will Pass
Publish date: March 10, 2020
Molecularly guided therapy improved overall survival in a retrospective study, but this treatment approach was underused.
News
- Author:
- Will Pass
Publish date: March 6, 2020
A classification of severe malnutrition was most predictive of mortality among patients with esophageal or colorectal cancer but not among patients...
News
- Author:
- Will Pass
Publish date: March 5, 2020
Patients who received the regimen had significantly better event-free survival, compared with historical controls.
News
- Author:
- Will Pass
Publish date: March 2, 2020
Recent studies showed that colibactin, a toxin produced by pks+ E. coli, causes a specific type of DNA damage.
News
- Author:
- Will Pass
Publish date: February 28, 2020
The team deployed a variety of strategies that included patient-centered change and physician education.
News
- Author:
- Will Pass
Publish date: February 26, 2020
Response rate and progression-free survival were significantly better with olaparib than with nonplatinum chemotherapy.
News
- Author:
- Will Pass
Publish date: February 22, 2020
A new scoring system can predict response to immunotherapy in patients with melanoma, lung cancer, and kidney cancer.
